Nurix Therapeutics, Inc.·4

Nov 10, 7:19 AM ET

DANSEY ROGER D 4

4 · Nurix Therapeutics, Inc. · Filed Nov 10, 2025

Insider Transaction Report

Form 4
Period: 2025-11-06
Transactions
  • Award

    Director Stock Option (right to buy)

    2025-11-06+50,00050,000 total
    Exercise: $12.52Exp: 2035-11-06Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The stock option vests as to 1/36 of the total shares monthly beginning December 6, 2025 until the option is fully vested on November 6, 2028, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Documents

1 file
  • 4
    wk-form4_1762777138.xmlPrimary

    FORM 4